Transient occult hepatitis B virus infection in a blood donor with high viremia

Transfusion

Volumn 49, Issue 8, 2009, Pages 1621-1629

  Gerlich, Wolfram H ^a   Bremer, Corinna M ^b   Saniewski, Mona ^b   Wend, Ulrike C ^b   Torres, Pilar ^b   Lelie, Nico ^b   Glebe, Dieter ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MACROGOL; VIRUS DNA;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; BLOOD DONOR; CASE REPORT; CLINICAL FEATURE; DENSITY GRADIENT CENTRIFUGATION; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPRECIPITATION; MOLECULAR CLONING; NONHUMAN; NONSENSE MUTATION; VIREMIA; VIRUS MUTATION;

BLOOD DONORS; DNA, VIRAL; DONOR SELECTION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; TIME FACTORS; VIREMIA;

EID: 68149094127     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02188.x     Document Type: Article

References (32)

1. Gerlich WH, Glebe D, Schüttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 2007 14 Suppl 1 : 16 21.
2. Hoofnagle JH, Gerety RJ, Barker LF. Hepatitis B core antigen and antibody. Dev Biol Stand 1975 30 : 175 85.
3. Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schüttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E. HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007 79 : 32 6.
4. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004 86 : 83 91.
5. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 2006 36 Suppl 1 : S23 9.
6. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007 46 : 160 70.
7. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008 49 : 652 7.
8. Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, Pollicino T. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008 48 : 743 6.
9. Burger R, Offergeld R. [Testing plasma donations for hepatitis B core antigen (anti-HBc) in order to improve safety of cellular blood components and of quarantined fresh frozen plasma]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005 48 : 698 9.
10. Furtwängler M, Edwards A, Cyran E, Wend U, Gerlich WH. Nosokomiale Hepatitis-B-Übertragungen. Deutsches Ärzteblatt 2006 103 : 1084 7.
11. Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002 42 : 869 75.
12. Minegishi K, Yoshikawa A, Kishimoto S, Yugi H, Yokoya N, Sakurada M, Kiyokawa H, Nishioka K Japanese Red Cross NAT Screening Research Group. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sang 2003 84 : 287 91.
13. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
14. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H Japanese Red Cross NAT Screening Research Group. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007 47 : 1162 71.
15. Jursch CA, Gerlich WH, Glebe D, Schaefer S, Marie O, Thraenhart O. Molecular approaches to validate disinfectants against human hepatitis B virus. Med Microbiol Immunol 2002 190 : 189 97.
16. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A WHO collaborative Study Group. An international collaborative study to establish a WHO international standard for hepatitis B virus DNA nucleic amplification techniques. Vox Sang 2001 63 71. (Pubitemid 35333911)
17. Heermann KH, Gerlich WH, Chudy M, Schaefer S, Thomssen R. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol 1999 37 : 68 73.
18. Günther S, Li BC, Miska S, Krüger DH, Meisel H, Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995 69 : 5437 44.
19. Madalinski K, Burczynska B, Heermann KH, Uy A, Gerlich WH. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus. Clin Exp Immunol 1991 84 : 493 500.
20. Sominskaya I, Pushko P, Dreilina D, Kozlovskaya T, Pumpens P. Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes. Med Microbiol Immunol 1992 181 : 215 26.
21. Sobotta D, Sominskaya I, Jansons J, Meisel H, Schmitt S, Heermann KH, Kaluza G, Pumpens P, Gerlich WH. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol 2000 81 : 369 78.
22. Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P, Leadbetter G, Murray K. Hepatitis B virus genes and their expression in E. coli. Nature 1979 282 : 575 9.
23. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996 70 : 5845 51.
24. Glebe D, Aliakbari M, Krass P, Knoop EV, Valerius KP, Gerlich WH. PreS1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 2003 77 : 9511 21.
25. Chulanov VP, Shipulin GA, Schaefer S, Gerlich WH. Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 2003 69 : 313 23.
26. Torresi J, Earnest-Silveira L, Civitico G, Walters TE, Lewin SR, Fyfe J, Locarnini SA, Manns M, Trautwein C, Bock TC. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 2002 299 : 88 99.
27. Bock CT, Schwinn S, Locarnini S, Fyfe J, Manns MP, Trautwein C, Zentgraf H. Structural organization of the hepatitis B virus minichromosome. J Mol Biol 2001 307 : 183 96.
28. Milich DR. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 1988 9 : 380 6.
29. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A 1994 91 : 3764 8.
30. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003 77 : 68 76.
31. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 1990 87 : 6599 603.
32. Manzini P, Abate ML, Valpreda C, Milanesi P, Curti F, Rizzetto M, Smedile A. Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor. Transfusion 2009 Jan 2. [Epub ahead of print ].